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Throughout the fertile years, the male and female reproductive organs (testes and ovaries) pro-duce gametes (sperm and ova) 
which, through sexual intercourse, may 
fuse to form an embryo. The production of 
gametes is orchestrated by a cascade of 
hormones and growth factors, many of 
which have complex effects on the body. In 
middle and old age, the reproductive sys-
tems undergo significant changes: a 
gradual decline in fertility and fluctua-
tions in the production of sex hormones, 
the latter triggering anatomical and physi-
ological changes in distant organs and tis-
sues. This article examines these changes 
and explores some of the treatments avail-
able to alleviate their consequences.
Female reproductive system
Ovaries
As women age, there is a progressive 
decline in the number of ovarian follicles, 
which gains speed in the fourth decade of 
life; the number and quality of ova 
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diminish and oestrogen production 
declines, which in most women triggers 
the menopause around the age of 51. The 
speed of ovarian ageing is determined pri-
marily by genetics, although oxidative 
stress, apoptosis and environmental fac-
tors also play a role. Premature ovarian 
failure (POF) can be triggered by surgery, 
radio- or chemotherapy, autoimmune 
reactions, and infections caused, for 
example, by the mumps virus and cyto-
megalovirus (Amanvermez and Tosun, 
2016; Broekmans et al, 2009).
The perimenopause 
In women, the first episode of menstrual 
bleeding (menarche) marks the onset of 
puberty. The prime child-bearing years 
correspond to the period between 
menarche and perimenopause (Dutton 
and Rymer, 2015). Before the menopause, 
when menstruation ceases and women 
become infertile, the hormones that drive 
the menstrual cycle start to fluctuate. This 
perimenopausal phase, which can last 2-10 
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Menopausal woman are also at risk of 
urinary incontinence: the bladder and ure-
thra are sensitive to oestrogen (both have 
oestrogen receptors), so it seems likely 
that decreased oestrogen levels contribute 
to urethral shrinkage and urinary inconti-
nence (Santoro et al, 2015). Breast tissue is 
also oestrogen sensitive and women often 
notice a loss of supporting connective 
tissue in the breasts (Chahal and Drake, 
2007); age-related skin thinning and loss of 
skin elasticity can exacerbate this. 
Mood changes and depression
Fluctuating concentrations of FSH, oes-
trogen and progesterone are often associ-
ated with mood changes. Despite incon-
sistencies in the literature, it is generally 
accepted that normal fluctuations in hor-
mone levels – whether in the premenstrual 
stage of the menstrual cycle, during preg-
nancy or in the perimenopausal years – can 
be associated with negative psychological 
symptoms. The perimenopause is also 
associated with poor memory and concen-
tration, problems with other people and 
low self-esteem. Other psychological 
symptoms are anxiety, irritability and 
rapid mood swings, but not necessarily low 
mood (Freeman, 2015; Cohen et al, 2005). 
A previous history of depression or pre-
menstrual syndrome is associated with an 
increased risk of clinical depression in the 
perimenopause and menopause. Women 
may also have pre-existing pathologies – 
such as metabolic syndrome, osteoporosis 
or cardiovascular disease – that are associ-
ated with depression and depressive symp-
toms. It is unclear if there is an increased 
risk of clinical depression in the perimeno-
pause (Freeman, 2015), so clinical depression 
should not be regarded as a normal feature 
of either perimenopause or menopause.
Hot flushes
Around three in four women experience 
hot flushes in the perimenopause and 
menopause (Bit.ly/NHSCHoicesHotFlushes). 
They are described as a rapid heat increase, 
particularly in the face, neck and chest, 
often with sweating and palpitations. The 
length of time women experience them 
varies between 4 and 10 years; most experi-
ence them every day and a third have more 
than 10 a day (Committee on Practice Bul-
letins – Gynecology, 2014). 
Hot flushes appear to be related to 
increased levels of FSH and decreased 
levels of oestrogen. Decreased oestrogen 
seems to affect serotonin levels in the 
hypothalamus, causing fluctuations in the 
set point of the thermoregulatory centre; 
this leads to vasodilation and increased 
blood flow in the skin (Santoro et al, 2015).
Vaginal atrophy and dryness 
The menopause is associated with a loss of 
elasticity and shrinkage in the length of 
the vagina. The epithelial lining becomes 
thinner and infiltrated by neutrophils, 
while the production of natural lubri-
cating secretions slows down, increasing 
the risk of tears, bleeding and infection. In 
this changing environment, faecally 
derived species of bacteria may become 
dominant over the lactobacilli populations 
typically seen in premenopausal women. 
Lactobacilli produce lactic acid, so their 
depletion reduces the acidity of the vagina, 
resulting in a neutral or alkali pH that can 
encourage the growth of Candida albicans 
and other micro-organisms (Milsom, 
2006). These vaginal changes can make 
sexual intercourse uncomfortable or painful 
(dyspareunia), and can reduce libido; 
27-60% of menopausal women are affected 
by vaginal dryness and dyspareunia. 
years, is often accompanied by increasing 
irregularity of the menstrual cycle. 
Although perimenopausal women are still 
fertile, pregnancy becomes more difficult. 
The symptoms of the perimenopause 
are similar to those of the menopause. 
Some women experience few symptoms, 
but for others the perimenopause can be 
extremely challenging, since fluctuating 
hormone levels can cause physical and 
psychological symptoms such as hot 
flushes, night sweats, mood swings and 
feelings of sadness (Wagner, 2016).
The menopause
The irregular menstrual cycles character-
istic of the perimenopause eventually 
cease completely. Strictly speaking, the 
menopause is the cessation of periods for 
12 months (Goodman et al, 2011). In most of 
the world it occurs in the early 50s, with 
some variation. Around 95% of women go 
through the menopause between 44 and 56 
years, the average age being 50.7 (Freeman, 
2015). Many factors that precipitate POF 
can also trigger early menopause (Dutton 
and Rymer, 2015). Since no more ova are 
being released, it is impossible for post-
menopausal women to become pregnant 
without fertility treatment.
Hormonal changes
Follicle-stimulating hormone (FSH), 
secreted by the pituitary gland, drives the 
menstrual cycle. It stimulates the develop-
ment of ovarian follicles, and as these 
enlarge they secrete the female sex hor-
mone oestrogen. In perimenopausal and 
menopausal women, FSH levels remain 
high – or are higher than in premenopausal 
women – but FSH is unable to stimulate 
follicular development. Eventually, follic-
ular activity ceases altogether, leading to a 
rapid decline in oestrogen secretion. 
Similarly, luteinising hormone, which 
triggers ovulation, is secreted at normal or 
higher than normal levels (Burger et al, 
2007), but without mature follicles, no ova 
can be released so menopausal women 
become infertile. 
Symptoms and clinical features
As during puberty and pregnancy, the 
transition to and through menopause is 
associated with dramatic fluctuations in 
the sex hormones oestrogen and proges-
terone. Symptoms are diverse and some-
times unique to the individual, but there 
are four that most women experience to 
varying degrees: hot flushes, vaginal dry-
ness, mood changes and sleep distur-
bances (Santoro et al, 2015).
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Fig 1. Ageing of the female reproductive tract
Uterus: Loss of muscle and eventual 
cessation of menstrual cycle
Ovaries: Reduction in number of ovarian 
follicles maturing leads to gradual decline 
in fertility. Levels of oestrogen begin to 
drop, triggering the menopause – 
typically around age of 51
Fallopian tubes: 
Shrinkage in length, loss 
of ciliated epithelia and 
loss of mucosa 
contribute to loss of 
fertility
Vagina: Loss of elasticity, shortening in 
length, reduction in vaginal secretions and 
thinning of epithelial lining all increase risk 
of tears, bleeding and infection
Opening of the cervix: 
Reduced cervical 
secretions
Uterus
Fundus
Body
Cervix
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The andropause
Although most men do not experience the 
profound physiological and psychological 
changes that many women go through, 
they do undergo hormonal changes indic-
ative of the so-called andropause – often 
inaccurately referred to as the male meno-
pause (Chahal and Drake, 2007). In their 
30s, men start to experience a decline in 
serum testosterone levels of around 1-1.4% 
per year. This is thought to be due to a 
reduction in the number of interstitial 
cells that synthesise testosterone and a 
reduced availability of free testosterone in 
the blood (Matsumoto, 2002). 
Physiological and psychological 
symptoms
Compared with the literature on the peri-
menopause and menopause, there is little 
research on the andropause. Reduced tes-
tosterone levels are associated with various 
physiological and psychological changes: 
●	 	Increased body fat (usually visceral);
●	 	Reduced muscle and bone mass;
●	 	ED and reduced libido;
●	 	Increased risk of anaemia;
●	 	Memory problems;
●	 	Sadness;
●	 	Irritability;
●	 	Loss of facial and pubic hair;
●	 	Lethargy;
●	 	Decreased endurance (Jakiel et al, 2015).
Penis and erectile dysfunction
Reduced testosterone levels can cause the 
penis to shrink, both in its flaccid and erect 
states. However, in most men, the earliest 
symptom of the andropause is a loss of 
libido, often accompanied with problems 
achieving an erection and maintaining it 
to the point of orgasm. The number of 
erections decreases and weaker erections 
become more common. Men who smoke 
The cervix (neck of the womb) consists 
of a smooth muscle layer overlaid by a 
mucus-producing cervical epithelium. 
Cervical mucus is essential to female fer-
tility, aiding sperm to pass through the 
cervical aperture and enhancing sperm 
motility and maturation. The menopause 
is associated with a reduction in cervical 
secretions which contributes to reducing 
fertility (Gorodeski, 2000).
Male reproductive system
Testes and sperm ducts
Most men show an age-related reduction 
in testicular mass (Chahal and Drake, 2007) 
with an associated reduction in testos-
terone and sperm production. Since sper-
matozoa are produced in huge numbers, 
most men remain fertile until their 80s and 
90s, although erectile dysfunction (ED) 
may be a problem. The sperm ducts, which 
carry sperm from the testes during ejacula-
tion, gradually become less elastic because 
of an accumulation of collagen (sclerosis). 
Prostate gland and seminal vesicles
The secretions from the seminal vesicles 
and prostate gland, which form the semen 
in which sperm swim, decrease with age, 
so the volume of ejaculate is reduced. Due 
to the parallel decrease in sperm numbers, 
sperm concentration remains fairly con-
stant, which helps maintain male fertility. 
Secretions from the prostate contain anti-
bacterial factors, so their decrease may 
increase the risk of urinary tract infection. 
A common age-related problem is 
benign prostatic hypertrophy (BPH), a 
gradual, non-malignant increase in the 
size of the prostate contributing to age-
related micturition difficulties. BPH may 
cause symptoms that are similar to those 
of prostate cancer, so investigations may 
be needed to rule out malignancy.
Sleep disturbances
Sleep problems become more common 
with age. In women, the risk of insomnia is 
41% greater than in men. Around 25% of 
women aged 50-64 report sleep problems – 
rising to 50% in postmenopausal women 
(Santoro et al, 2015; Ameratunga et al, 
2012). Many reasons for sleep disturbances 
during the menopause have been sug-
gested: hot flushes and night sweats, anx-
iety, depressive symptoms and sexual dys-
function (Jehan et al, 2015). Not all studies 
agree that the menopause is directly linked 
to sleep problems. A recent study showed 
no statistically significant differences in 
sleep quality between premenopausal and 
menopausal women (Tao et al, 2016).
Decreased bone health
Reduced oestrogen levels can lead to a 
decrease in bone density and increased risk 
of fractures. Menopausal women lose up to 
15% of their bone mass (Riggs and Melton, 
1986). Significant losses in the spongy bone 
of the vertebrae contribute to the curva-
ture of the spine often seen in postmeno-
pausal women with osteoporosis.
Fallopian tubes
Shrinkage in the length of the Fallopian 
tubes, loss of ciliated epithelia and loss of 
mucosa have been reported (Hwang and 
Song, 2004). Since the Fallopian tubes are 
the site of fertilisation and are responsible 
for transporting the fertilised ovum to the 
uterus, these changes contribute to the age-
related reduction in fertility, and may 
explain why older women are at increased 
risk of ectopic pregnancy (Bouyer et al, 2003).
Uterus and cervix
The endometrium is the inner mucosal 
layer of the uterus that is shed during men-
struation and then rebuilt under the influ-
ence of oestrogens. When oestrogen pro-
duction decreases, this rebuilding is 
gradually compromised, until it becomes 
impossible and menstruation ceases. 
The myometrium, the middle layer of 
the uterus, is composed almost entirely of 
smooth muscle fibres. In childbirth its 
contractions push the baby through the 
birth canal. In the menopause, it begins to 
shrink. Oestrogen helps to maintain the 
myometrium, so its reduction is thought 
to contribute to the loss of smooth muscle 
fibres – although the mechanisms of myo-
metrial atrophy remain unclear (Mwampa-
gatwa et al, 2013). 
The perimetrium – the thin outer 
serous layer of the uterus – appears to 
change little with age. 
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Fig 2. Ageing of the male reproductive tract
Bladder
Prostate: Decreased secretions from 
the seminal vesicles and prostate gland 
lead to reduced volume of ejaculate. 
Benign prostatic hypertrophy may 
compress urethra, making urination 
difficult
Penis: Reduced testosterone levels can 
cause shrinking and erectile dysfunction
Testes: Reduced testicular mass leads 
to reduction in sperm production and 
testosterone secretion. Sperm ducts 
gradually become less elastic
CA
TH
ER
IN
E H
OL
LIC
K
Copyright EMAP Publishing 2017 
This article is not for distribution
47Nursing Times [online] September 2017 / Vol 113 Issue 9 www.nursingtimes.net
the Menopause: 21st Century Solutions. 
Cambridge: Cambridge University Press.
Freeman EW (2015) Depression in the menopause 
transition: risks in the changing hormone milieu as 
observed in the general population. Women’s 
Midlife Health; 1: 2, 1-11.
Goodman NF et al (2011) American Association of 
Clinical Endocrinologists Medical Guidelines for 
Clinical Practice for the diagnosis and treatment of 
menopause. Endocrine Practice; 17(Suppl6): 1-25.
Gorodeski GI (2000) Effects of menopause and 
estrogen on cervical epithelial permeability. 
Journal of Clinical Endocrinology and Metabolism; 
85: 7, 2584-2595.
Hardy R et al (2008) Body mass index trajectories 
and age at menopause in a British birth cohort. 
Maturitas; 59: 4, 304-314.
Hwang TS, Song J (2004) Morphometrical 
changes of the human uterine tubes according to 
aging and menstrual cycle. Annals of Anatomy; 
186: 3, 263-269.
Hyland A et al (2016) Associations between 
lifetime tobacco exposure with infertility and age 
at natural menopause: the Women’s Health 
Initiative Observational Study. Tobacco Control; 25: 
6, 706-714.
Jakiel G et al (2015) Andropause – state of the art 
2015 and review of selected aspects. Menopause 
Review; 14: 1, 1-6.
Jehan S et al (2015) Sleep disorders in 
postmenopausal women. Journal of Sleep 
Disorders and Therapy; 4: 5, 1000212.
Matsumoto AM (2002) Andropause: clinical 
implications of the decline in serum testosterone 
levels with aging in men. Journals of Gerontology. 
Series A, Biological Sciences and Medical Sciences; 
57: 2, M76-99.
Milsom I (2006) Menopause-related symptoms 
and their treatment. In: Erkkola R (ed) European 
Practice in Gynaecology and Obstetrics. No 9. The 
Menopause. Edinburgh: Elsevier.
Mwampagatwa IH et al (2013) Morpho-
physiological features associated with menopause: 
recent knowledge and areas for future work. 
Tanzania Journal of Health Research; 15: 2, 93-101.
Nandy PR (2008) Male andropause: a myth or 
reality. Medical Journal Armed Forces India; 64: 3, 
244-249.
National Institute for Health and Care Excellence 
(2017) Benefits and risks of hormone replacement 
therapy. Bit.ly/NICEMenopausePathway
Riggs BL, Melton LJ (1986) Involutional 
osteoporosis. New England Journal of Medicine; 
314: 26, 1676-1686.
Saccomani S et al (2017) Does obesity increase 
the risk of hot flashes among midlife women? A 
population-based study. Menopause [Epub]. 
Santoro et al (2015) Menopausal symptoms and 
their management. Endocrinology and Metabolisn 
Clinics of North America; 44: 3, 497-515.
Sengupta P, Nwagha U (2014) The aging sperm: is 
the male reproductive capacity ticking to 
biological extinction? Journal of Basic and Clinical 
Reproductive Sciences; 3: 1, 1-7.
Sofimajidpour H et al (2015) The effect of 
testosterone on men with andropause. Iranian Red 
Crescent Medical Journal; 17: 12, e19406.
Sood R et al (2014) Prescribing menopausal 
hormone therapy: an evidence-based approach. 
International Journal of Women’s Health; 6: 47-57.
Tao MF et al (2016) Poor sleep in middle-aged 
women is not associated with menopause per se. 
Brazilian Journal of Medical and Biological 
Research; 49: 1, e4718.
Wagner D (2016) Perimenopause: The untold 
story. Obstetrics and Gynecology International 
Journal; 5: 1, 00139.
Modifiable risk factors
The ageing of the reproductive tracts, and 
the changes and symptoms brought about 
by the menopause and andropause, are 
inevitable. However, certain lifestyle 
changes may delay, or reduce the effects of 
the menopause or andropause – although 
some of the evidence is contradictory. 
Smoking is the main modifiable risk 
factor. The inhalation of cigarette smoke 
increases the risk of infertility and early 
menopause in women, and the same risks 
exist for women exposed to second-hand 
smoking (Hyland et al, 2016). In men, 
smoking increases the risk of ED and 
lowers sperm count and quality (Sengupta 
and Nwagha, 2014). 
A low body mass index (BMI) and being 
undernourished are both associated with 
an earlier menopausal onset. The effect of 
an increased BMI is less clear: some studies 
show that it is linked with a later meno-
pausal onset (Akahoshi et al, 2002), others 
suggest no influence (Hardy et al 2008). A 
high BMI and obesity seem to be associated 
with more severe hot flushes and other 
perimenopausal symptoms (Saccomani et 
al, 2017). In men, a high BMI is associated 
with lower circulating testosterone levels, 
which can exacerbate the effects of the 
andropause (Bansal, 2013). NT
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or have pre-existing pathologies such as 
diabetes, blood pressure problems or ath-
erosclerotic occlusion are at higher risk of 
ED. Today, ED can be treated by techniques 
such as counselling and medications such 
as sildenafil (Viagra) (Bansal, 2013).
Hormone replacement therapy
In women
Some effects of the perimenopause and 
menopause can be alleviated by hormone 
replacement therapy (HRT) – usually 
either oestrogen alone or oestrogen and 
progesterone given orally or transdermally. 
HRT has been reported to be effective in: 
●	 	Treating osteoporosis and reducing the 
risk of bone fractures;
●	 	Improving muscle strength;
●	 	Reducing vaginal dryness;
●	 	Reducing hot flushes and night sweats;
●	 	Improving sleep;
●	 	Reducing headaches;
●	 	Improving memory;
●	 	Reducing panic attacks.
HRT carries certain risks and there is 
growing evidence that HRT (particularly 
oestrogen plus progesterone) increases the 
risk of breast cancer (Sood et al, 2014). Evi-
dence of other risks of HRT is conflicting.
In men
There has been much research into the 
benefits and risks of HRT in women, but 
HRT in men going through the andro-
pause has received less attention. Recent 
research has shown that testosterone 
replacement therapy (TRT) can have posi-
tive effects (Sofiajidpour et al, 2015). 
However, increasing the level of circu-
lating testosterone is associated with a 
variety of side-effects and risks including 
oily skin, acne, increased haematocrit 
count, gynaecomastia (breast tissue devel-
opment) and increased risk of prostate 
cancer. The effect of TRT on cardiovascular 
health remains unclear (Nandy et al, 2008).
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